<DOC>
	<DOCNO>NCT01147458</DOCNO>
	<brief_summary>PF-04191834 work animal model inhibit one enzyme , 5-lipoxygenasein involved pathway cause inflammation pain . The purpose study test effective , safe tolerate PF-04191834 patient osteoarthritis knee naproxen , particularly test patient less pain .</brief_summary>
	<brief_title>A Study Of The Safety And Efficacy Of PF-04191834 In Patients With Osteoarthritis Of The Knee</brief_title>
	<detailed_description>This study terminate response report serious adverse event ( SAE ) . The sponsor 's assessment limit data available time initial SAE report SAE may alter potential benefit - risk profile study medication .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis , Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Subjects must diagnosis osteoarthritis base American College Rheumatology criterion confirm Xray Subjects must willing able stop current pain therapy duration study Subjects must willing able complete daily diary BMI &gt; 39 kg/m2 Known allergy hypersensitivity naproxen Any condition medical history might interfere subject 's ability complete study visit assessment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>May 2013</verification_date>
	<keyword>Cross-over</keyword>
	<keyword>safety</keyword>
	<keyword>efficacy</keyword>
	<keyword>tolerability</keyword>
	<keyword>osteoarthritis</keyword>
	<keyword>knee</keyword>
	<keyword>pain</keyword>
</DOC>